Barrett esophagus in Asia: Same disease with different pattern

Clinical Endoscopy

Volumn 47, Issue 1, 2014, Pages 15-22

  Lee, Hyun Seok ^a   Jeon, Seong Woo ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Barrett esophagus; Prevalence; Risk factors

Indexed keywords

EID: 84893143016     PISSN: 22342400     EISSN: 22342443     Source Type: Journal    
DOI: 10.5946/ce.2014.47.1.15     Document Type: Article

References (80)

1. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004;127:310-330.
2. Wang KK, Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008;103:788-797.
3. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997;92:1293-1297.
4. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96(5 Pt 1):1249-1256.
5. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009;373:850-861.
6. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009;24:729-735.
7. Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol 2006;21:1362-1365.
8. Azuma N, Endo T, Arimura Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000;35:583-592.
9. Chen X, Zhu LR, Hou XH. The characteristics of Barrett's esophagus: an analysis of 4120 cases in China. Dis Esophagus 2009;22:348-353.
10. Chang CY, Cook MB, Lee YC, et al. Current status of Barrett's esophagus research in Asia. J Gastroenterol Hepatol 2011;26:240-246.
11. Corley DA, Kubo A, Levin TR, et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 2009;58:182-188.
12. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-1289.
13. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006;107:2160-2166.
14. Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 2002;287:1972-1981.
15. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-1831.
16. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-1677.
17. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus 2010;23:451-457.
18. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54: 710-717.
19. Fock KM, Ang TL. Global epidemiology of Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2011;5:123-130.
20. Choi CY, Suh S, Park JS, et al. The prevalence of Barrett's esophagus and the comparison of Barrett's esophagus with cardiac intestinal metaplasia in the health screening at a secondary care hospital. Korean J Gastroenterol 2012;60:219-223.
21. Xiong LS, Cui Y, Wang JP, et al. Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J Dig Dis 2010;11:83-87.
22. Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 1997;42:702-706.
23. Zhang M, Fan XS, Zou XP. The prevalence of Barrett's esophagus remains low in Eastern China. Single-center 7-year descriptive study. Saudi Med J 2012;33:1324-1329.
24. Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009;41: 1011-1017.
25. Amano Y, Kushiyama Y, Yuki T, et al. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol 2006;41:873-879.
26. Akiyama T, Inamori M, Akimoto K, et al. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig Dis Sci 2009;54:1702-1707.
27. Okita K, Amano Y, Takahashi Y, et al. Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol 2008;43: 928-934.
28. Lee IS, Choi SC, Shim KN, et al. Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig Dis Sci 2010;55:1932-1939.
29. Kim JH, Rhee PL, Lee JH, et al. Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol 2007;22:908-912.
30. Dhawan PS, Alvares JF, Vora IM, et al. Prevalence of short segments of specialized columnar epithelium in distal esophagus: association with gastroesophageal reflux. Indian J Gastroenterol 2001;20:144-147.
31. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004;16:495-501.
32. Odemiş B, Ciçek B, Zengin NI, et al. Barrett's esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study. Dis Esophagus 2009;22:649-655.
33. Chang CY, Lee YC, Lee CT, et al. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol 2009;104:13-20.
34. Khamechian T, Alizargar J, Mazoochi T. The prevalence of Barrett's esophagus in outpatients with dyspepsia in Shaheed Beheshti Hospital of Kashan. Iran J Med Sci 2013;38:263-266.
35. Amano Y, Ishimura N, Furuta K, et al. Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 2006;64:206-211.
36. Choi DW, Oh SN, Baek SJ, et al. Endoscopically observed lower esophageal capillary patterns. Korean J Intern Med 2002;17:245-248.
37. Kuo CJ, Lin CH, Liu NJ, Wu RC, Tang JH, Cheng CL. Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig Dis Sci 2010;55:1337-1343.
38. Fujiwara Y, Higuchi K, Shiba M, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atro phic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol 2003;38:533-539.
39. Park JJ, Kim JW, Kim HJ, et al. The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol 2009;43:907-914.
40. Tseng PH, Lee YC, Chiu HM, et al. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J Clin Gastroenterol 2008;42:1074-1079.
41. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig Dis Sci 2004;49:237-242.
42. Takubo K, Vieth M, Aida J, et al. Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 2009; 80:248-257.
43. Ho KY. From GERD to Barrett's esophagus: is the pattern in Asia mirroring that in the West? J Gastroenterol Hepatol 2011;26:816-824.
44. Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Endoscopy 2010;42:699-704.
45. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-1399.
46. Spechler SJ. Short and ultrashort Barrett's esophagus: what does it mean? Semin Gastrointest Dis 1997;8:59-67.
47. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57:298-305.
48. Parfitt JR, Miladinovic Z, Driman DK. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada: an epidemiological study from 1964-2002. Can J Gastroenterol 2006;20:271-276.
49. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005;54 Suppl 1:i1-i5.
50. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008;168:237-249.
51. Miyazaki T, Inose T, Tanaka N, et al. Management of Barrett's esophageal carcinoma. Surg Today 2013;43:353-360.
52. Committee for Scientific Affairs, Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2011;59:636-667.
53. Kazui T, Wada H, Fujita H; Japanese Association for Thoracic Surgery Committee of Science. Thoracic and cardiovascular surgery in Japan during 2003: annual report by The Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg 2005;53:517-536.
54. Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol 2006;101:1430-1436.
55. Chung JW, Lee GH, Choi KS, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification. Dis Esophagus 2009;22:676-681.
56. Yee YK, Cheung TK, Chan AO, Yuen MF, Wong BC. Decreasing trend of esophageal adenocarcinoma in Hong Kong. Cancer Epidemiol Biomarkers Prev 2007;16:2637-2640.
57. Streitz JM Jr, Ellis FH Jr, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998; 93:911-915.
58. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94:2043-2053.
59. Neumann CS, Cooper BT. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus. Gut 1994;35:1352-1355.
60. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999;117: 572-580.
61. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol 1994;89:349-356.
62. Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999;94:2054-2059.
63. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty KM. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter 2007;12:177-183.
64. Hirschowitz BI. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sci 1996;41:1384-1391.
65. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-754.
66. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-1199.
67. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.
68. Abe Y, Iijima K, Koike T, et al. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. J Gastroenterol Hepatol 2009;24: 129-134.
69. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharmacol Ther 2004;20 Suppl 8:50-54.
70. Seidel D, Muangpaisan W, Hiro H, Mathew A, Lyratzopoulos G. The association between body mass index and Barrett's esophagus: a systematic review. Dis Esophagus 2009;22:564-570.
71. Akiyama T, Yoneda M, Inamori M, et al. Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2009;9:56.
72. Akiyama T, Yoneda M, Maeda S, Nakajima A, Koyama S, Inamori M. Visceral obesity and the risk of Barrett's esophagus. Digestion 2011;83: 142-145.
73. Weinsier RL, Hunter GR, Gower BA, Schutz Y, Darnell BE, Zuckerman PA. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 2001;74:631-636.
74. Akiyama T, Inamori M, Iida H, et al. Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men. BMC Gastroenterol 2008;8:58.
75. Lee SJ, Jung MK, Kim SK, et al. Clinical characteristics of gastroesophageal reflux disease with esophageal injury in korean: focusing on risk factors. Korean J Gastroenterol 2011;57:281-287.
76. Caygill CP, Johnston DA, Lopez M, et al. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol 2002;97:1328-1331.
77. Uno G, Amano Y, Yuki T, et al. Relationship between kyphosis and Barrett's esophagus in Japanese patients. Intern Med 2011;50:2725-2730.
78. Manabe N, Haruma K, Imamura H, et al. Does short-segment columnar- lined esophagus elongate during a mean follow-up period of 5.7 years? Dig Endosc 2011;23:166-172.
79. Huang Q, Fang DC, Fang JY, et al. How to diagnose and manage patients with Barrett's esophagus in China. J Dig Dis 2012;13:123-132.
80. Goda K, Singh R, Oda I, et al. Current status of endoscopic diagnosis and treatment of superficial Barrett's adenocarcinoma in Asia-Pacific region. Dig Endosc 2013;25 Suppl 2:146-150.